Abstract
Inflammatory bowel diseases (IBD) are multifactorial disorders characterised by the host's inability to limit the inflammatory response to luminal antigens. The association of polymorphisms in the CARD15 gene with Crohn's disease (CD) demonstrates the relevance of activated transcription factor NFκB in mononuclear cells. Interleukin 11 (IL11) mediates anti-inflammatory effects and is able to downregulate LPS-induced NFκB activation. The IL11 gene is therefore a good candidate involved in genetic predisposition to IBD. To evaluate the role of the IL11 gene in IBD, two polymorphisms, including a dinucleotide repeat in the promoter region, have been genotyped in 222 patients with CD, 152 patients with ulcerative colitis (UC) and 400 healthy controls. PCR-SSCP analysis of the coding region revealed a single polymorphism in exon 4 leading to an amino acid exchange (G335A; R112H), not significantly associated with either disease. Dinucleotide repeat frequencies of the IL11.A1 allele and of IL11.A1 homozygous individuals were significantly increased among the patients with UC (P<0.002 and (P<0.003, respectively) but not with CD. Altered expression of IL11 appears to be involved in the genetic predisposition of UC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Niessner M, Volk BA . Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR) Clin Exp Immunol 1995 101: 428–435
Kmiec Z . Cytokines in inflammatory bowel disease Arch Immunol Ther Exp 1998 46: 43–55
Gotteland M, Lopez M, Munoz C et al. Local and systemic liberation of proinflammatory cytokines in ulcerative colitis Dig Dis Sci 1999 44: 830–835
Schreiber S, Nikolaus S, Hampe J . Activation of nuclear factor kappa B in inflammatory bowel disease Gut 1998 42: 477–484
Russel MG, Pastoor CJ, Janssen KM et al. Familial aggregation of inflammatory bowel disease: a population-based study in South Limburg, The Netherlands. The South Limburg IBD Study Group Scand J Gastroenterol Suppl 1997 223: 88–91
Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP . The genetics of inflammatory bowel disease Ailment Pharmacol Ther 2001 15: 731–748
Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001 411: 599–603
Hampe J, Cuthbert A, Croucher PJ et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations Lancet 2001 357: 1925–1928
Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G . Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB J Biol Chem 2001 276: 4812–4818
Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ . Hematopoietic, immunomodulatory and epithelial effects of interleukin-11 Leukemia 1999 13: 1307–1315
Bozza M, Bliss JL, Dorner AJ, Trepicchio WL . Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells J Interferon Cytokine Res 2001 21: 21–30
Mahboubi K, Li F, Plescia J et al. Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway Lab Invest 2001 81: 327–334
Grosfeld JL, Du X, Williams DA . Interleukin-11: its biology and prospects for clinical use J Parenter Enteral Nutr 1999 23: (Suppl.) 67–69
Trepicchio WL, Wang L, Bozza M, Dorner AJ . IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB J Immunol 1997 159: 5661–5670
Bellingham J, Gregory-Evans K, Gregory-Evans CY . A polymorphic dinucleotide repeat in the 5′ flanking region of the human interleukin 11 (IL11) gene Immunogenetics 1998 47: 499–500
Lennard-Jones JE . Classification of inflammatory bowel disease Scand J Gastroenterol Suppl 1989 170: 2–6
Epplen C, Jackel S, Santos EJ et al. Genetic predisposition to Multiple Sclerosis as revealed by immunoprinting Ann Neurol 1997 41: 341–352
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215
Epplen JT, Kyas A, Maueler W . Genomic simple repetitive DNAs are targets for differential binding of nuclear proteins FEBS Lett 1996 389: 92–95
Hamada H, Seidman M, Howard BH, Gorman CM . Enhanced gene expression by the poly(dT-dG) poly(dC-dA) sequence Mol Cell Biol 1984 4: 2622–2630
Trepicchio WL, Ozawa M, Walters IB et al. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions J Clin Invest 1999 104: 1527–1537
Feinglass S, Deodhar A . Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11 Arthritis Rheum 2001 44: 70–75
Peterson RL, Wang L, Albert L, Keith JC Jr, Dorner AJ . Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease Lab Invest 1998 78: 1503–1512
Sands BE, Bank S, Sninsky CA et al. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease Gastroenterology 1999 117: 58–64
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klein, W., Tromm, A., Griga, T. et al. A polymorphism in the IL11 gene is associated with ulcerative colitis. Genes Immun 3, 494–496 (2002). https://doi.org/10.1038/sj.gene.6363897
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363897
Keywords
This article is cited by
-
The expression analysis of Fra-1 gene and IL-11 protein in Iranian patients with ulcerative colitis
BMC Immunology (2018)
-
Genetic Susceptibility in Inflammatory Bowel Disease
Clinical Reviews in Bone and Mineral Metabolism (2010)
-
Looking back and looking forward
Genes & Immunity (2003)